Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

A secondary analysis of NCT04889183. The report of the trial’s main result is not on the map, and the numbers here are shown and do not vote.

What the trial testedrandomised · 101 people · 2026

Randomised comparison

Doesn’t vote: a later paper about the trial

−9.10−11.0 to −7.20

As reported

difference −9.1, 95% CI −11.0 to −7.20

Randomised comparison

Doesn’t vote: a later paper about the trial

−0.90−1.60 to −0.10

As reported

difference −0.9, 95% CI −1.60 to −0.10

the abstract, start to end

… weight, lean body mass, and fat mass by -9.1 (95% confidence interval [CI], …

… extracellular water and systolic BP by -0.9 (95% CI, -1.6 to -0.1) L and …

← favours treatmentfavours comparator →

could be chance

Body weight & composition

−9.1−11.0 to −7.20

Blood pressure

−0.9−1.60 to −0.10

GLP-1 receptor agonistsBody weight & compositionBlood pressure

1 / 3

2026

this papercites it